BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3949565)

  • 1. Hodgkin's disease: is there a price for successful treatment? A 25-year experience.
    Rubin P; Zagars G; Chuang C; Thomas EM
    Int J Radiat Oncol Biol Phys; 1986 Feb; 12(2):153-66. PubMed ID: 3949565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second malignant neoplasms in patients treated for Hodgkin's disease with radiotherapy or radiotherapy and chemotherapy.
    Nelson DF; Cooper S; Weston MG; Rubin P
    Cancer; 1981 Dec; 48(11):2386-93. PubMed ID: 7296488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two cycles of MOPP and radiotherapy for stage III1A and stage III1B Hodgkin's disease.
    Henkelmann GC; Hagemeister FB; Fuller LM
    J Clin Oncol; 1988 Aug; 6(8):1293-302. PubMed ID: 3411342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Second neoplasms as a late complication of the treatment of Hodgkin's disease].
    Morales MD; González FA; Villegas A; del Potro E; Díaz Mediavilla J; Martínez R; Alvarez A; Colomé JA
    Sangre (Barc); 1992 Dec; 37(6):429-33. PubMed ID: 1293793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second primary malignant neoplasms in patients treated for Hodgkin's disease at St Bartholomew's Hospital.
    Dorreen MS; Gregory WM; Wrigley PF; Stansfeld AG; Lister TA
    Hematol Oncol; 1986; 4(2):149-61. PubMed ID: 3755696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of second cancers in patients treated for Hodgkin's disease.
    Boivin JF; Hutchison GB; Zauber AG; Bernstein L; Davis FG; Michel RP; Zanke B; Tan CT; Fuller LM; Mauch P
    J Natl Cancer Inst; 1995 May; 87(10):732-41. PubMed ID: 7563150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
    Fermé C; Eghbali H; Meerwaldt JH; Rieux C; Bosq J; Berger F; Girinsky T; Brice P; van't Veer MB; Walewski JA; Lederlin P; Tirelli U; Carde P; Van den Neste E; Gyan E; Monconduit M; Diviné M; Raemaekers JM; Salles G; Noordijk EM; Creemers GJ; Gabarre J; Hagenbeek A; Reman O; Blanc M; Thomas J; Vié B; Kluin-Nelemans JC; Viseu F; Baars JW; Poortmans P; Lugtenburg PJ; Carrie C; Jaubert J; Henry-Amar M;
    N Engl J Med; 2007 Nov; 357(19):1916-27. PubMed ID: 17989384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The balance between cure and late effects in childhood Hodgkin's lymphoma: the experience of the German-Austrian Study-Group since 1978. German-Austrian Pediatric Hodgkin's Disease Study Group.
    Schellong G
    Ann Oncol; 1996; 7 Suppl 4():67-72. PubMed ID: 8836413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of stages I and II Hodgkin's disease with three different therapeutic modalities.
    Koziner B; Myers J; Cirrincione C; Redman J; Cunningham I; Caravelli J; Nisce LZ; McCormick B; Straus DJ; Mertelsmann R
    Am J Med; 1986 Jun; 80(6):1067-78. PubMed ID: 3755285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fifteen-year experience in Hodgkin's disease: role of combined modality treatment and splenectomy in the incidence of secondary acute leukemia.
    Zinzani PL; Fiacchini M; Mazza P; Gherlinzoni F; Bocchia M; Tura S
    Haematologica; 1991; 76(4):305-10. PubMed ID: 1724437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hodgkin's disease stages IA and IIA. A long-term follow-up study on the gains achieved by modern therapy.
    Zagars G; Rubin P
    Cancer; 1985 Oct; 56(8):1905-12. PubMed ID: 4027927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. British National Lymphoma Investigation randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease--long term results.
    Hancock BW; Vaughan Hudson G; Vaughan Hudson B; Haybittle JL; Bennett MH; MacLennan KA; Jelliffe AM
    Br J Cancer; 1991 Apr; 63(4):579-82. PubMed ID: 2021542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: eight-year update of an Italian prospective randomized study.
    Biti GP; Cimino G; Cartoni C; Magrini SM; Anselmo AP; Enrici RM; Bellesi GP; Bosi A; Papa G; Giannarelli D
    J Clin Oncol; 1992 Mar; 10(3):378-82. PubMed ID: 1740677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hodgkin's disease: summary of twenty years' experience.
    Mazza P; Bocchia M; Zinzani PL; Fiacchini M; Gherlinzoni F; Bandini G; Bendandi M; Frezza GP; Neri S; Barbieri E
    Haematologica; 1992; 77(6):487-93. PubMed ID: 1283856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-stage Hodgkin's disease: long-term results with radiotherapy alone or combined radiotherapy and chemotherapy.
    Brusamolino E; Lazzarino M; Orlandi E; Canevari A; Morra E; Castelli G; Alessandrino EP; Pagnucco G; Astori C; Livraghi A
    Ann Oncol; 1994; 5 Suppl 2():101-6. PubMed ID: 7515642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute nonlymphocytic leukemia after treatment for Hodgkin's disease.
    Aisenberg AC
    Am J Med; 1983 Sep; 75(3):449-54. PubMed ID: 6688502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
    Longo DL; Glatstein E; Duffey PL; Young RC; Ihde DC; Bastian AW; Wilson WH; Wittes RE; Jaffe ES; Hubbard SM; DeVita VT
    J Clin Oncol; 1997 Nov; 15(11):3338-46. PubMed ID: 9363863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second malignancies after treatment for Hodgkin's disease.
    Várady E; Deák B; Molnár ZS; Rosta A; Schneider T; Esik O; Eckhardt S
    Leuk Lymphoma; 2001; 42(6):1275-81. PubMed ID: 11911408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined chemotherapy-radiotherapy in advanced Hodgkin's disease: results of a prospective clinical trial with 70 stage IIIB-IV patients.
    Fermé C; Lepage E; Brice P; D'Agay MF; Fermand JP; Castaigne S; Frija J; Miot C; Marty M; Gisselbrecht C
    Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):397-405. PubMed ID: 7685749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.